Detalhe da pesquisa
1.
Feasibility of Short-Term Aggressive Lipid-Lowering Therapy with the PCSK9 Antibody in Acute Coronary Syndrome.
J Cardiovasc Dev Dis
; 10(5)2023 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37233171